BioSpace News Archive

Pomerantz LLP announces that a class action lawsuit has been filed against Aclaris Therapeutics Inc. and certain of its officers.

Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. and certain of its officers.

Competition was developed to encourage intersection of IT with life sciences research on two Hoosier health issues - diabetes and opioid addiction

Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, announced the voting results from its annual and special meeting of shareholders held on Thursday, September 26, 2019.

Samsung Bioepis Co., Ltd. announced results from the Phase 3 study evaluating the efficacy and safety of SB8, a bevacizumab biosimilar candidate, compared to reference bevacizumab in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC).

MAVYRET® (glecaprevir/pibrentasvir) is now available as the only 8-week pan-genotypic treatment option for treatment-naïve chronic hepatitis C (HCV) patients, without cirrhosis or with compensated cirrhosis

The Arizona Bioindustry Association (AZBio) announced that Marti Lindsey, PhD, community engagement director for the Southwest Environmental Health Sciences Center at the University of Arizona College of Pharmacy and founder and co-director of the KEYS High School Student Internship program at the UA BIO5 Institute, will be honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year at the AZBio Awards on Oct. 2, 2019.

Indivior PLC announces that the National Institutes of Health has granted Indivior’s application entitled “Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder” pursuant to Funding Opportunity Announcement RFA-DA-19-002 dedicated to the development of medications to prevent and treat opioid use disorder and overdose.

At the Indiana Life Sciences Summit, BioCrossroads’ Board of Directors named Dr. Clem J. McDonald recipient of the 2019 August M. Watanabe Life Sciences Champion of the Year Award.

Aurinia Pharmaceuticals Inc. announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 at 1:15 p.m. ET in New York, NY.